Coriell Institute for Medical Research
Request a Quote
Careers
Login
View Cart
Samples
OR
Website
Search Help?
Sample Catalog
|
Custom Services
|
Core Facilities
|
Genomic Data Search
Navigation Header
Biobank
NIGMS
NINDS
NIA
NHGRI
Allen Cell Collection
Rett Syndrome iPSC Collection
Autism Research Resource
HD Community Biorepository
CDC Cell and DNA
NEI
J. Craig Venter Institute
Orphan Disease Center Collection
Phase Clinical Services
All Biobanks
Research
Overview
Meet Our Scientists
Our Faculty
Our Scientific Staff
Camden Cancer Research Center
Epigenetic Therapies SPORE
Core Facilities
Epigenomics
Camden Opioid Research Initiative (CORI)
The Issa & Jelinek Lab
The Jian Huang Lab
The Luke Chen Lab
The Lab
The Team
Publications
The Scheinfeldt Lab
The Shumei Song Lab
The Nora Engel Lab
The Lab
The Team
Publications
Coriell Personalized Medicine Collaborative (CPMC)
Publications
Services
Stem Cells
Biobanking and Distribution
Biobanking
Biological and Pharmaceutical Storage
Collection Kits
Coriell Marketplace
Research Support Services
Sample Procurement
Cellular and Molecular Analysis
Genomic and Epigenomic Services
Nucleic Acid Isolation and Quality Control
Customized Experimental Design and Research Solutions
Biomarkers
Cell Culture
Research and Development Models
Browse
Stem Cells
Cell Lines
DNA and RNA
Featured Products
FFPE
HMW DNA
Genomic Data Search
Diseases
Rare Diseases
Species
Gene Variants, Mutations
Notable Collections
GRC
REGARDS
Amish Major Affective Disorders
Longevity Research
Search by Catalog ID
Search Help
Ordering
Create Account
Order Online
Ordering FAQ
FAQs/Culture Instructions
Reference Materials
Biobanks
NIGMS Repository
NHGRI Repository
NINDS Repository
NIA Repository
NIST
GeT-RM
MTA Assurance Form
Shipment Policy
Contact Customer Service
Donate
Our Message
Your Impact
Giving FAQs
Make a Donation
About Us
Our History
Meet Our Team
Meet Our Board
Education
Science Fair
Summer Experience
Outreach
Research Program Internship
Press Room
Press Releases
Coriell Blog
Annual Report
Careers
Working at Coriell
Current Openings
Giving
Our Message
Your Support in Action
Giving FAQ
Giving Tuesday
Contact Us
Legal Notice
Login
View Cart
search submit
ND35201
DNA
from
Whole Blood
Description:
PARKINSON DISEASE
Affected:
Yes
Gender:
Female
Age:
61
YR
(At Sampling)
Sample Description
Overview
Characterizations
Phenotypic Data
External Links
Overview
Repository
NINDS Repository
Subcollection
Parkinsonism
Quantity
3 µg
Quantitation Method
Please see our
FAQ
Biopsy Source
Peripheral vein
Sample Source
DNA from Whole Blood
Race
White
Ethnicity
Hispanic/Latino
Country of Origin
USA
Family Member
1
Family History
N
Species
Homo
sapiens
Common Name
Human
Note
This material represents a finite resource (DNA from Whole Blood)
Characterizations
Gene
PARK2
Chromosomal Location
6q25.2-q27
Allelic Variant 1
602544.0005
; PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE
Identified Mutation
EX3DEL
; To determine the frequency of deletions in the PARK2 gene, Lucking et al. (1998) searched for homozygous deletions in the PARK2 gene in 12 PARK2-linked families with autosomal recessive juvenile parkinsonism (600116) and known or suspected consanguinity (a total of 32 patients). Five of the families originated from Italy, 4 from France, 1 from the Netherlands, 1 from Portugal, and 1 from Algeria. Six of the families had previously been reported by Tassin et al. (1998). They found 2 novel homozygous deletions in 8 patients from 3 families. The Algerian family carried a deletion of exons 8 and 9. Deletions of exon 3 were found in 1 French and 1 Portuguese family. Deletions in the PARK2 gene accounted, therefore, for only a quarter of the PARK2-linked families with known or suspected consanguinity, which suggested that point mutations may be more prominent. Mean age at onset and clinical severity were similar in the deleted and nondeleted families. The overall clinical features were also similar, except that patients with exon 3 deletions had significantly lower frequencies of tremor than the nondeleted patients, a significantly later mean age at onset than those with exon 8-9 deletions, and a trend toward greater severity for similar disease durations. Both deletions were expected to cause frameshifts introducing a premature stop codon and resulting in truncated proteins with probable loss of function. The exon 3 deletion might have more harmful effects, leading to a shorter truncated protein, since these patients were more severely affected. The exon 8-9 deletion was, however, associated with earlier age at onset, as if the less truncated protein resulted in an additional toxic effect.
Phenotypic Data
Demographic Data
Relation to Proband
No Data
Age at Sampling
61 YR
Gender
Female
Age of Onset(If not a control)
14 YR
Age at Diagnosis(If not a control)
18 YR
Hispanic or Latino/Not Hispanic or Latino
Hispanic/Latino
Racial Category
White
Country
USA
Diagnosed By
No Data
Data Elements
Clinical Element Type: Parkinsonism
(Baseline)
Longitudinal Data
Is this data Longitudinal (Follow-Up) Data?
yes
no
Family History
Family history of parkinsonism
present
absent
unknown (subject adopted)
Notes:
MOTHER, 2 BROTHERS, > 4 SECOND DEGREE RELATIVES
Specific diagnosis
Parkinsonism clinical diagnosis
Parkinson's disease
Progressive Supranuclear Palsy
Diffuse Lewy Body Disease
Multiple System Atrophy
Others
Unaffected primary blood relative of proband
Genetic Data of Subject
Mutation/s in subject's DNA (if present, describe)
present
absent
unknown
Notes:
PARK2 EXON 3 DEL HOMOZYGOTE
Signs suggestive of PD diagnosis
Asymmetric onset
present
absent
Bradykinesis
No Data
Activation tremor
present
absent
Resting Tremor
present
absent
Postural Instability
present
absent
Rigidity
present
absent
Gait difficulties
present
absent
Response to Anti-Parkinsonism Therapy
tried and responsive
inadequate dose
not tried/not given
tested and unresponsive
Signs suggestive of another diagnosis
history of strokes or stepwise deterioration
present
absent
history of head injury with loss of consciousness
present
absent
history of encephalitis
present
absent
Oculogyric crisis
present
absent
neuroleptic treatment at time of symptom onset
present
absent
sustained remission
present
absent
gaze palsy
present
absent
Cerebellar signs
present
absent
Fluctuations in attention or alertness
present
absent
hallucinations
present
absent
dysautonomia
present
absent
Significant cognitive impairment or dementia
present
absent
axial rigidity
present
absent
Other
present
absent
Smoking History
smoking history
never
former smoker
current smoker
years smoking
No Data
Optional data
Mini-mental status score
No Data
Hoehn and Yahr
3.5
UPDRS total motor score
No Data
Handedness
Right
Left
Ambidextrous
External Links
NCBI GTR
168600 PARKINSON DISEASE, LATE-ONSET; PD
OMIM
168600 PARKINSON DISEASE, LATE-ONSET; PD
Omim Description
PARKINSON DISEASE 1
PARKINSON DISEASE; PD
PARKINSONISM
Culture Protocols
Supplement
-
Pricing
Commercial and Non-U.S.:
$0.00
USD
U.S. Academic or
Non-profit:
$0.00
USD
NINDS Repository Submitter (past or current) and/or Current NINDS Grantee
$0.00
USD
Add to Cart
How to Order
Ordering Instructions
MTA / Assurance Form
Statement of Research Intent Form
Related Products
Same Family
NINDS4398